Dexamethasone sodium phosphatecontains not less than 97.0 per cent and not more than the equivalent of 103.0 per cent of 9-fluoro-11β, 17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-yl disodium phosphate(C22H28FNa2O8P), calculated on the anhydrous, ethanol-free substance.
共有 1 個藥物證書使用此成份
- 申請商
- 台灣荃新股份有限公司
- 適應症
- 醣類代謝皮質素
- 含量
- 發證日期
- 2013-02-26